Bandini® Creatine Monohydrate 3000mg - 300 Tablets - Supplement for Energy, Training and Gym - Pre Workout for Men & Women - Powder Alternative - 100% Vegan Micronized Creatin - Keto Unflavoured

Show on Amazon

Offer

i

Price trend

Product description

  • HIGH DOSAGE, HIGH PERFORMANCE. Our creatine is a dietary supplement in tablet form that contains 100% creatine monohydrate. The daily dose provides 3000 mg of micronised creatine monohydrate. Each pack contains 300 tablets, which equates to a total of 100 doses. Our creatine tablets are easy to take and, unlike creatine powder, leave no aftertaste.
  • PROPERTIES. Creatine is recommended for adult athletes. Creatine can be taken before, during or after training.
  • CONSUMPTION METHOD. Creatine is produced by the body from the three amino acids glycine, arginine and methionine. The organism therefore produces creatine naturally, but in small quantities, and excretes it daily. BandiniPharma therefore offers you a high-quality creatine supplement to support your daily training and sporting activities. The recommended dose is 3 tablets per day with plenty of water. Packaging may vary
  • TESTED QUALITY Our supplements are high quality, vegan, GMO-free and produced without undesirable additives, colourings or preservatives. Our priority is to develop and bring to market innovative supplements that are traceable, of high quality and with high bioavailability. We produce vegan supplements, without undesirable additives, never GMOs and guarantee the highest level of safety in all our products.
  • CERTIFIED PRODUCT. Bandini Pharma is an Italian company able to offer innovative products, in a dynamic and professional way our products are made in our GMP, UNI EN ISO 9001 2015 and ISO 22000 certified laboratory. Our Creatine is Halal certified. The Bandini Sport Nutrition line, entirely made in Italy, includes a wide range of products with an excellent quality-price ratio.

You might also be interested in these creatine tablets 5000mg.

© 2025 WHICH.ONE. ALL CONTENT IS SUBJECT TO OUR COPYRIGHT.